Nuvectis Pharma, Inc. (NASDAQ:NVCT) appears in 47 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 845,502 | 146,794 | 21.01% | $6,383,541.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 782,805 | 97,468 | 14.22% | $5,910,179.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 764,441 | -18,364 | -2.35% | $5,909,128.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 659,879 | 659,879 | 0.00% | $5,100,865.00 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 31 Dec, 2025 | 586,320 | 180,699 | 44.55% | $4,426,716.00 |
| Occam Crest Management LP | 31 Dec, 2025 | 407,147 | 27,147 | 7.14% | $3,147,246.00 |
| BALDWIN WEALTH PARTNERS LLC/MA | 31 Dec, 2025 | 389,625 | 39,164 | 11.17% | $2,941,669.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 384,105 | 20,081 | 5.52% | $2,969,729.00 |
| Occam Crest Management LP | 31 Dec, 2025 | 380,000 | 90,000 | 31.03% | $2,869,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 364,024 | 38,291 | 11.76% | $2,748,937.00 |
| State Street Corp | 31 Dec, 2025 | 166,516 | 11,850 | 7.66% | $1,287,169.00 |
| State Street Corp | 31 Dec, 2025 | 154,666 | 17,950 | 13.13% | $1,167,728.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 134,154 | 43,275 | 47.62% | $1,012,863.00 |
| Northern Trust Corp | 31 Dec, 2025 | 124,212 | 7,807 | 6.71% | $960,159.00 |
| Northern Trust Corp | 31 Dec, 2025 | 116,405 | 9,764 | 9.16% | $878,857.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Dec, 2025 | 114,842 | 114,842 | 0.00% | $887,729.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 105,286 | -28,868 | -21.52% | $813,861.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Dec, 2025 | 92,154 | 92,154 | 0.00% | $712,350.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 78,425 | 78,425 | 0.00% | $606,225.00 |
| OPPENHEIMER & CO INC | 31 Dec, 2025 | 73,566 | 4,500 | 6.52% | $555,423.00 |